Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management

JB Clain, S Scherl, L Dos Reis, A Turk, BM Wenig… - Thyroid, 2014 - liebertpub.com
Background: While there is consensus that significant extrathyroidal extension (ETE)(T4)
should upstage a patient with well-differentiated thyroid cancer, the importance of minimal …

Prognostic value of genetic mutations in thyroid cancer: a meta-analysis

K Pak, S Suh, SJ Kim, IJ Kim - Thyroid, 2015 - liebertpub.com
Background: Genetic mutations have been found to be associated with thyroid cancer.
Previous studies have been focused on the relation between genetic mutations and thyroid …

Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma

SK Kim, JW Woo, JH Lee, I Park, JH Choe, JH Kim… - Surgery, 2015 - Elsevier
Background The extent of surgery for papillary thyroid carcinoma (PTC) is associated
strongly with disease persistence, recurrence, and mortality. It is difficult, however, to …

[HTML][HTML] BRAF V600E mutation in papillary thyroid carcinoma: its relation to clinical features and oncologic outcomes in a single cancer centre experience

M Al-Masri, T Al-Shobaki, H Al-Najjar… - Endocrine …, 2021 - ec.bioscientifica.com
Purpose This study focuses on the oncologic influence of BRAF V600E mutations in a cohort
of Middle Eastern papillary thyroid carcinoma (PTC) patients treated at a single centre. We …

[HTML][HTML] Real-life use of BRAF-V600E mutation analysis in thyroid nodule fine needle aspiration: consequences on clinical decision-making

G Brigante, A Craparo, E Pignatti, M Marino… - Endocrine, 2021 - Springer
Purpose This study aimed to evaluate the real-life use of BRAF-V600E mutation analysis in
washout liquid from thyroid nodule fine needle aspiration (FNA), and the consequences of …

Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in …

AS Harahap, I Subekti, SS Panigoro… - The Application of …, 2023 - Taylor & Francis
Introduction BRAF V600E and RAS mutations are the most common gene mutations in
papillary thyroid carcinoma (PTC) that may be correlated with its biological behavior. There …

Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer

ZY Abd Elmageed, AB Sholl, K Tsumagari… - Surgery, 2017 - Elsevier
Background BRAF V600E mutation has been investigated by immunohistochemistry and
has shown high sensitivity and specificity. We aim to investigate the accuracy of …

[HTML][HTML] FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5

Y Huang, H Jin, Y Liu, J Zhou, J Ding… - Endocrine-related …, 2011 - erc.bioscientifica.com
The impact of metastasized cervical lymph nodes (CLN) identified on central neck dissection
(CND) on the recurrence/persistence of papillary thyroid cancer (PTC) and the extent of …

[PDF][PDF] Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?

BHH Lang, YJ Chai, BJ Cowling, HS Min… - Endocrine-related …, 2014 - erc.bioscientifica.com
Abstract Utilizing BRAF V600E mutation as a marker may reduce unnecessary prophylactic
central neck dissection (pCND) in clinically nodal negative (cN0) neck for small (≤ 2 cm) …

The sentinel lymph node biopsy technique in papillary thyroid carcinoma: The issue of false-negative findings

LM Garau, D Rubello, S Muccioli, G Boni… - European Journal of …, 2020 - Elsevier
Background The management of papillary thyroid carcinoma (PTC) is changed after
introduction of sentinel lymph node biopsy (SNB) technique for nodal staging. Some debate …